Leaning on lessons from cetuximab-resistant models in HNSCC, we identified that blockade of SFK activity resulted in decreased Y1101 phosphorylation and accumulation of EGFR on the cellular membrane. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.